Type 1 Diabetes Trial, Recruiting NCT07573228 Sponsor: University of Virginia Condition: Type 1 Diabetes
Back to Type 1 Diabetes

Type 1 Diabetes Trial, Recruiting

NCT07573228
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 21 and 50 years old (male or female)
  • If you have Type 1 diabetes (T1D): you have had it for at least 5 years and your recent average blood sugar level (HbA1c) is 8.5% or below, managed with daily insulin injections or an insulin pump
  • Your body mass index (BMI — a measure based on height and weight) falls within a specific range depending on which group you are in: roughly 19–27 for healthy controls and those with T1D only, or roughly 30–40 (or 27.5–37.5 for Asian Americans) for those in the obesity or T1D-plus-obesity groups
  • Any non-insulin medications you take have been used at a stable dose for more than 6 months (hormonal medications like estrogen or progesterone must have been stopped at least 3 months before the study; however, hormonal IUDs may be allowed due to low absorption into the body)

Who may not be able to join:

  • You have any significant illness or health condition other than Type 1 diabetes or obesity
  • You have a history of diabetes-related complications affecting small or large blood vessels (such as eye, kidney, or nerve damage, or heart/circulation problems)
  • You have had a serious diabetes emergency called diabetic ketoacidosis in the past 2 years
  • You have a condition where you cannot feel the warning signs of low blood sugar (hypoglycemia unawareness)
  • You currently exercise at a moderate or high intensity for more than 20 minutes, at least twice a week
  • You currently smoke or have quit smoking within the last 5 years
  • You have very high levels of triglycerides (a type of fat in the blood) above 400 mg/dl
  • You currently take certain blood pressure or heart-related medications, including calcium channel blockers, ACE inhibitors, angiotensin-receptor blockers, nitrates, alpha- or beta-blockers, or water pills (diuretics)
  • You are a woman who has taken oral contraceptives (birth control pills) in the past 3 months
  • You have a significant history of metabolic, heart, brain, blood, lung, digestive, liver, kidney, hormonal, or cancer-related conditions
  • You are currently pregnant (confirmed by a pregnancy test) or breastfeeding
  • You have a physical condition affecting your muscles or joints that would prevent you from doing exercise testing or training
  • You have a history of gastroparesis (a condition where the stomach empties too slowly)
  • Your blood oxygen level, measured by a pulse oximetry reading, is below 90% (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Zhenqi Liu, MD, University of Virginia

Phone: 434-924-5247

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
23 February 2026
Est. completion
30 June 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Microvascular blood volume in skeletal and cardiac muscle - changes from baseline; maximal aerobic exercise capacity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov